KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070,022 | -42.8% | 76,980 | -5.4% | 0.00% | 0.0% |
| Q2 2023 | $1,871,156 | -16.8% | 81,390 | +7.2% | 0.00% | 0.0% |
| Q1 2023 | $2,250,132 | +35.9% | 75,941 | +16.9% | 0.00% | 0.0% |
| Q4 2022 | $1,656,061 | +15.6% | 64,986 | -0.2% | 0.00% | 0.0% |
| Q3 2022 | $1,432,427 | +8.0% | 65,109 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $1,326,103 | -48.2% | 65,825 | +7.2% | 0.00% | -50.0% |
| Q1 2022 | $2,561,070 | +128.7% | 61,413 | +246.2% | 0.00% | +100.0% |
| Q4 2021 | $1,120,000 | +10.1% | 17,739 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $1,017,000 | +29.7% | 17,316 | +7.1% | 0.00% | 0.0% |
| Q2 2021 | $784,000 | +229.4% | 16,165 | +164.4% | 0.00% | – |
| Q1 2021 | $238,000 | -36.7% | 6,114 | +0.8% | 0.00% | – |
| Q4 2020 | $376,000 | – | 6,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |